Mark Mifflin is an Ophthalmology physician affiliated with University of Utah. OpenAlex indexes 73 publications with 1,392 citations (h-index 20); ClinicalTrials.gov lists 5 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingClinical trials
- Loteprednol vs. Prednisolone and Fluorometholone
Sponsor: University of Utah
- 70 vs 110 Degree Side-cut Angles in Femtosecond LASIK
Sponsor: University of Utah
- Topo-guided LASIK and Photorefractive Keratectomy vs Wavefront LASIK and Photorefractive Keratectomy
Sponsor: University of Utah
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Similar KOLs
Other experts from the same institution or the same specialty.
Howard Colman, MD
University of Utah
Mark Rapaport, MD
University of Utah
Daniel Clegg, MD
University of Utah
Dennis Shrieve, MD
University of Utah
Robert Weinreb, MD
University of California San Diego
Emily Chew, MD
National Eye Institute
Harry Quigley, MD
Johns Hopkins University School of Medicine
Joel Schuman, MD
Wills Eye Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”